Amphastar Pharmaceuticals (AMPH) Short Interest Ratio & Short Volume $29.19 -0.20 (-0.68%) Closing price 04:00 PM EasternExtended Trading$29.33 +0.14 (+0.48%) As of 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Amphastar Pharmaceuticals Short Interest DataAmphastar Pharmaceuticals (AMPH) has a short interest of 4.13 million shares, representing 12.07% of the float (the number of shares available for trading by the public). This marks a 2.74% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.6, indicating that it would take 7.6 days of the average trading volume of 617,114 shares to cover all short positions.Current Short Interest4,130,000 sharesPrevious Short Interest4,020,000 sharesChange Vs. Previous Month+2.74%Dollar Volume Sold Short$123.20 millionShort Interest Ratio7.6 Days to CoverLast Record DateAugust 15, 2025Outstanding Shares46,490,000 sharesFloat Size34,220,000 sharesShort Percent of Float12.07%Today's Trading Volume553,530 sharesAverage Trading Volume617,114 sharesToday's Volume Vs. Average90% Short Selling Amphastar Pharmaceuticals? Sign up to receive the latest short interest report for Amphastar Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAMPH Short Interest Over TimeAMPH Days to Cover Over TimeAMPH Percentage of Float Shorted Over Time Amphastar Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/20254,130,000 shares $123.20 million +2.7%12.1%7.6 $29.83 7/31/20254,020,000 shares $84.22 million +0.3%11.8%7.6 $20.95 7/15/20254,010,000 shares $84.93 million -1.2%11.6%7.9 $21.18 6/30/20254,060,000 shares $93.22 million -0.5%11.7%7.3 $22.96 6/15/20254,080,000 shares $105.35 million -0.5%11.8%7.3 $25.82 5/31/20254,100,000 shares $106.11 million +2.2%11.8%7 $25.88 5/15/20254,010,000 shares $97.52 million +24.9%11.5%6.4 $24.32 4/30/20253,210,000 shares $78.36 million +8.1%9.2%5.1 $24.41 4/15/20252,970,000 shares $69.80 million -13.2%8.5%4.9 $23.50 3/31/20253,420,000 shares $99.15 million -11.2%9.7%5.5 $28.99 Get the Latest News and Ratings for AMPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amphastar Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 3/15/20253,850,000 shares $102.64 million -6.8%10.9%6.2 $26.66 2/28/20254,130,000 shares $117.42 million +1.5%11.6%6.9 $28.43 2/15/20254,070,000 shares $126.25 million -1.2%11.3%7.4 $31.02 1/31/20254,120,000 shares $143.66 million -10.4%11.5%7.5 $34.87 1/15/20254,600,000 shares $166.70 million -4.6%12.9%8.8 $36.24 12/31/20244,820,000 shares $178.97 million +10.3%13.5%10.1 $37.13 12/15/20244,370,000 shares $184.59 million +6.1%12.2%10.3 $42.24 11/30/20244,120,000 shares $186.18 million -2.8%11.5%11 $45.19 11/15/20244,240,000 shares $189.15 million -2.3%11.8%12 $44.61 10/31/20244,340,000 shares $219.30 million +2.6%12.2%12.6 $50.53 10/15/20244,230,000 shares $208.58 million -2.8%11.7%12 $49.31 9/30/20244,350,000 shares $211.11 million +5.3%12.0%11.9 $48.53 9/15/20244,130,000 shares $198.61 million -1.9%11.4%10.4 $48.09 8/31/20244,210,000 shares $205.20 million No Change12.0%11.2 $48.74 8/15/20244,210,000 shares $190.80 million -7.5%12.0%10.9 $45.32 7/31/20244,550,000 shares $198.02 million +7.6%12.9%11.6 $43.52 7/15/20244,230,000 shares $163.95 million +1.4%12.0%11.7 $38.76 6/30/20244,170,000 shares $166.80 million +0.5%11.9%11.5 $40.00 6/15/20244,150,000 shares $168.03 million +10.4%11.8%12.1 $40.49 5/31/20243,760,000 shares $159.16 million -0.3%10.3%10.3 $42.33 5/15/20243,770,000 shares $160.00 million -5.5%10.7%9.2 $42.44 4/30/20243,990,000 shares $164.59 million +3.1%11.4%9.7 $41.25 4/15/20243,870,000 shares $157.82 million +5.5%11.0%9 $40.78 3/31/20243,670,000 shares $161.15 million +1.9%10.6%7.8 $43.91 3/15/20243,600,000 shares $154.98 million -3.2%10.4%7.5 $43.05 2/29/20243,720,000 shares $173.24 million +3.6%10.3%7.5 $46.57 2/15/20243,590,000 shares $199.28 million +12.5%10.0%7.9 $55.51 1/31/20243,190,000 shares $170.22 million +8.5%8.9%6.6 $53.36 1/15/20242,940,000 shares $159.38 million +5.8%8.2%6.5 $54.21 12/31/20232,780,000 shares $171.94 million -1.8%7.8%6.5 $61.85 12/15/20232,830,000 shares $160.18 million -0.7%8.0%6.9 $56.60 11/30/20232,850,000 shares $160.51 million -1.4%8.0%6 $56.32 11/15/20232,890,000 shares $166.23 million +15.6%8.1%6.4 $57.52 10/31/20232,500,000 shares $113.18 million -6.0%6.9%5.7 $45.27 10/15/20232,660,000 shares $121.72 million +1.5%7.3%6.2 $45.76 9/30/20232,620,000 shares $120.49 million -2.6%7.2%5.8 $45.99 9/15/20232,690,000 shares $123.12 million +106.9%7.4%5.9 $45.77 8/31/20231,300,000 shares $69.30 million -12.8%3.6%3 $53.31 8/15/20231,490,000 shares $85.30 million +4.2%4.1%3.4 $57.25 7/31/20231,430,000 shares $86.79 million -30.9%4.0%3.2 $60.69 7/15/20232,070,000 shares $115.65 million +3.0%5.8%4.5 $55.87 6/30/20232,010,000 shares $115.51 million -3.4%5.6%4.5 $57.47 6/15/20232,080,000 shares $108.64 million +10.6%5.8%4.7 $52.23 5/31/20231,880,000 shares $83.42 million -1.1%5.3%4.7 $44.37 5/15/20231,900,000 shares $79.34 million +2.2%5.3%4.8 $41.76 4/30/20231,860,000 shares $66.53 million +29.2%5.3%5.3 $35.77 4/15/20231,440,000 shares $60.70 million +9.9%4.1%4.5 $42.15 3/31/20231,310,000 shares $49.13 million -10.3%3.7%4.6 $37.50 3/15/20231,460,000 shares $53.79 million -16.6%4.1%5.7 $36.84 2/28/20231,750,000 shares $55.76 million +1.2%4.7%7.4 $31.86 2/15/20231,730,000 shares $56.33 million +0.6%4.6%8.3 $32.56 1/31/20231,720,000 shares $52.05 million +1.2%4.6%8.1 $30.26 1/15/20231,700,000 shares $49.23 million -1.2%4.6%7.9 $28.96 12/30/20221,720,000 shares $48.19 million -2.3%4.6%7.9 $28.02 12/15/20221,760,000 shares $50.65 million -0.6%4.8%7.9 $28.78 11/30/20221,770,000 shares $52.20 million -3.8%4.8%7.7 $29.49 11/15/20221,840,000 shares $52.20 million -5.2%5.0%7.5 $28.37 10/31/20221,940,000 shares $59.95 million +1.6%5.2%6.9 $30.90 10/15/20221,910,000 shares $54.49 million +1.1%5.1%6.6 $28.53 9/30/20221,890,000 shares $53.11 million -9.1%5.0%6.2 $28.10 9/15/20222,080,000 shares $61.01 million -5.0%5.6%6 $29.33 8/31/20222,190,000 shares $64.82 million +1.4%5.9%5.1 $29.60 8/15/20222,160,000 shares $70.26 million -5.7%5.8%4.2 $32.53 7/31/20222,290,000 shares $85.62 million -3.0%6.1%4.1 $37.39 7/15/20222,360,000 shares $87.41 million +2.6%6.3%4.2 $37.04 6/30/20222,300,000 shares $80.02 million -11.5%6.2%3.8 $34.79 6/15/20222,600,000 shares $81.43 million +11.1%7.0%4.3 $31.32 5/31/20222,340,000 shares $86.91 million -6.8%6.3%4.3 $37.14 5/15/20222,510,000 shares $88.70 million +6.8%6.8%5.1 $35.34 4/30/20222,350,000 shares $83.35 million +15.2%6.4%5 $35.47 4/15/20222,040,000 shares $84.74 million +4.6%5.5%4.4 $41.54 3/31/20221,950,000 shares $70.01 million -3.5%5.4%4.7 $35.90 3/15/20222,020,000 shares $70.17 million +1.5%5.5%5.5 $34.74 2/28/20221,990,000 shares $55.14 million -2.9%5.5%6.3 $27.71 2/15/20222,050,000 shares $54.12 million +5.7%5.6%7.2 $26.40 1/31/20221,940,000 shares $44.79 million -1.5%5.6%7.1 $23.09 1/15/20221,970,000 shares $49.98 million -2.0%5.7%9.2 $25.37 12/31/20212,010,000 shares $46.81 million -2.9%5.8%10 $23.29 12/15/20212,070,000 shares $46.26 million -2.4%6.0%11.3 $22.35 11/30/20212,120,000 shares $41.47 million +7.1%6.1%12.5 $19.56 11/15/20211,980,000 shares $41.88 million -14.3%5.7%11.9 $21.15 10/29/20212,310,000 shares $43.15 million +1.3%6.6%16.3 $18.68 10/15/20212,280,000 shares $43.57 million No Change6.5%15.2 $19.11 9/30/20212,280,000 shares $43.34 million -5.8%6.5%14.1 $19.01 9/15/20212,420,000 shares $43.27 million +0.8%6.9%12.5 $17.88 8/31/20212,400,000 shares $47.09 million +3.0%6.9%11 $19.62 8/13/20212,330,000 shares $45.67 million -2.5%6.7%10.5 $19.60 7/30/20212,390,000 shares $50.07 million -1.2%6.9%10.2 $20.95 7/15/20212,420,000 shares $48.45 million -0.8%7.0%11 $20.02 6/30/20212,440,000 shares $49.19 million -7.9%7.1%11.1 $20.16 6/15/20212,650,000 shares $52.95 million +1.9%7.7%14.4 $19.98 5/28/20212,600,000 shares $49.19 million No Change7.5%15.4 $18.92 5/14/20212,600,000 shares $50.86 million -1.1%7.5%13.4 $19.56 4/30/20212,630,000 shares $46.21 million +3.5%7.6%13.7 $17.57 4/15/20212,540,000 shares $44.20 million +2.8%7.3%13.5 $17.40 3/31/20212,470,000 shares $44.46 million +2.9%7.3%12.6 $18.00 3/15/20212,400,000 shares $46.46 million -6.6%7.1%11.2 $19.36 2/26/20212,570,000 shares $45.98 million +0.8%7.5%12 $17.89 2/12/20212,550,000 shares $48.81 million -1.9%7.5%13.1 $19.14 1/29/20212,600,000 shares $48.28 million +1.6%7.3%12.8 $18.57 1/15/20212,560,000 shares $49.31 million -4.1%7.1%12.6 $19.26 12/31/20202,670,000 shares $53.00 million +3.5%7.5%13.6 $19.85 12/15/20202,580,000 shares $48.63 million -3.4%7.2%13.5 $18.85 11/30/20202,670,000 shares $48.38 million -0.7%7.5%13.8 $18.12 11/15/20202,690,000 shares $52.11 million No Change7.5%14.3 $19.37 10/30/20202,690,000 shares $54.04 million -2.2%7.5%15.1 $20.09 10/15/20202,750,000 shares $57.37 million +2.6%7.7%14.1 $20.86 9/30/20202,680,000 shares $50.25 million +7.2%7.5%12.2 $18.75 9/15/20202,500,000 shares $48.75 million -1.2%7.0%10.6 $19.50 AMPH Short Interest - Frequently Asked Questions What is Amphastar Pharmaceuticals' current short interest? Short interest is the volume of Amphastar Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of August 15th, investors have sold 4,130,000 shares of AMPH short. 12.07% of Amphastar Pharmaceuticals' shares are currently sold short. Learn More on Amphastar Pharmaceuticals' current short interest. What is a good short interest ratio for Amphastar Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AMPH shares currently have a short interest ratio of 8.0. Learn More on Amphastar Pharmaceuticals's short interest ratio. Which institutional investors are shorting Amphastar Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amphastar Pharmaceuticals: Group One Trading LLC, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Amphastar Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.07% of Amphastar Pharmaceuticals' floating shares are currently sold short. Is Amphastar Pharmaceuticals' short interest increasing or decreasing? Amphastar Pharmaceuticals saw a increase in short interest during the month of August. As of August 15th, there was short interest totaling 4,130,000 shares, an increase of 2.7% from the previous total of 4,020,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Amphastar Pharmaceuticals' float size? Amphastar Pharmaceuticals currently has issued a total of 46,490,000 shares. Some of Amphastar Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Amphastar Pharmaceuticals currently has a public float of 34,220,000 shares. How does Amphastar Pharmaceuticals' short interest compare to its competitors? 12.07% of Amphastar Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Amphastar Pharmaceuticals: Nuvalent, Inc. (12.40%), Merus N.V. (5.87%), CRISPR Therapeutics AG (25.63%), TG Therapeutics, Inc. (14.84%), Cytokinetics, Incorporated (13.10%), Krystal Biotech, Inc. (12.02%), ACADIA Pharmaceuticals Inc. (5.92%), ADMA Biologics Inc (6.27%), Vaxcyte, Inc. (8.81%), PTC Therapeutics, Inc. (8.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks. What does it mean to sell short Amphastar Pharmaceuticals stock? Short selling AMPH is an investing strategy that aims to generate trading profit from Amphastar Pharmaceuticals as its price is falling. AMPH shares are trading down $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Amphastar Pharmaceuticals? A short squeeze for Amphastar Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AMPH, which in turn drives the price of the stock up even further. How often is Amphastar Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMPH, twice per month. The most recent reporting period available is August, 15 2025. More Short Interest Resources from MarketBeat Related Companies Nuvalent Short Squeeze Merus Short Squeeze CRISPR Therapeutics Short Squeeze TG Therapeutics Short Squeeze Cytokinetics Short Squeeze Krystal Biotech Short Squeeze ACADIA Pharmaceuticals Short Squeeze ADMA Biologics Short Squeeze Vaxcyte Short Squeeze PTC Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AMPH) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amphastar Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
